Clorox (NYSE:CLX) Given New $158.00 Price Target at JPMorgan Chase & Co.

Clorox (NYSE:CLXFree Report) had its price objective trimmed by JPMorgan Chase & Co. from $159.00 to $158.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a neutral rating on the stock.

Several other equities research analysts have also issued reports on CLX. Citigroup decreased their target price on Clorox from $165.00 to $155.00 and set a neutral rating for the company in a research report on Tuesday, April 16th. Deutsche Bank Aktiengesellschaft decreased their price objective on Clorox from $155.00 to $151.00 and set a hold rating for the company in a report on Wednesday, April 17th. DA Davidson reissued a neutral rating and issued a $162.00 price objective on shares of Clorox in a report on Wednesday, April 17th. The Goldman Sachs Group started coverage on Clorox in a report on Friday, March 1st. They issued a sell rating and a $140.00 price objective for the company. Finally, Barclays decreased their price objective on Clorox from $148.00 to $136.00 and set an underweight rating for the company in a report on Wednesday, April 10th. Four investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to data from MarketBeat.com, Clorox has an average rating of Hold and an average target price of $146.43.

Get Our Latest Analysis on Clorox

Clorox Trading Down 1.0 %

Shares of Clorox stock opened at $138.23 on Wednesday. The company has a market capitalization of $17.17 billion, a P/E ratio of 71.62, a price-to-earnings-growth ratio of 2.16 and a beta of 0.44. The company has a current ratio of 0.90, a quick ratio of 0.57 and a debt-to-equity ratio of 9.73. The stock has a fifty day simple moving average of $148.45 and a 200 day simple moving average of $143.17. Clorox has a 12-month low of $114.68 and a 12-month high of $176.24.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the firm posted $1.51 EPS. The business’s revenue was down 5.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Clorox will post 5.83 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.47%. Clorox’s dividend payout ratio is currently 248.71%.

Institutional Trading of Clorox

Large investors have recently modified their holdings of the business. Fortitude Family Office LLC bought a new stake in shares of Clorox during the 4th quarter valued at about $29,000. Venturi Wealth Management LLC lifted its position in Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after buying an additional 145 shares during the last quarter. Northwest Financial Advisors bought a new stake in Clorox in the 4th quarter worth approximately $29,000. Core Wealth Advisors Inc. bought a new stake in Clorox in the 4th quarter worth approximately $29,000. Finally, First United Bank & Trust bought a new stake in Clorox in the 4th quarter worth approximately $31,000. Institutional investors own 78.53% of the company’s stock.

About Clorox

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.